
- September/October 2015
- Volume 6
- Issue 5
The Role of the Specialty Pharmacist in Optimizing the Quality of Care for Patients with Psoriasis and Psoriatic Arthritis
The Role of the Specialty Pharmacist in Optimizing the Quality of Care for Patients with Psoriasis and Psoriatic Arthritis
Celia P. MacDonnell, BS Pharm, PharmD
Clinical Professor of Pharmacy University of Rhode Island College of PharmacyKingston, Rhode IslandAdjunct Associate Professor of Family MedicineBrown UniversityAlpert School of MedicineProvidence, Rhode Island
Molly MacDonnell, PharmD
Clinical PharmacistDepartment of PharmacyWalter Reed National Military Medical CenterBethesda, Maryland
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose.
Faculty
Celia P. MacDonnell, BS Pharm, PharmDMolly MacDonnell, PharmD
Pharmacy Times Office of Continuing Professional Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Nathalie Harden
Specialty Pharmacy Times Editorial Staff— Davy James
An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Objectives
At the completion of this activity, the participant will be able to:
- Identify common comorbidities, focusing on signs and symptoms of psoriasis and psoriatic arthritis and the need for increased recognition
- Demonstrate knowledge of the efficacy and safety of current and emerging treatments for psoriasis and psoriatic arthritis
- Characterize the major barriers to optimal adherence to psoriasis and psoriatic arthritis treatments and describe the role of the specialty pharmacist in overcoming them
- Examine the importance of patient education and awareness in improving treatment outcomes
Link to Activity:
Target audience: Specialty Pharmacists
Type of activity: Application
Release date: October 7, 2015
Expiration date: October 7, 2016
Estimated time to complete activity: 1.5 hours
Fee: This lesson is offered for free at www.pharmacytimes.org.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-15-130-H01-P. The activity is available for CE credit through October 7, 2016.
Articles in this issue
about 10 years ago
Stribild by Gilead Sciences, Incabout 10 years ago
Scientists Successfully Grow Hepatitis C Virus in the Lababout 10 years ago
Hepatitis C May Elevate Heart Disease Riskabout 10 years ago
Cirrhosis Underreported in Hepatitis C Patientsabout 10 years ago
PCSK9 Inhibitors: Smoothing the Path to Access and Valueabout 10 years ago
Current Legislation in the Battle Against Alzheimer's Diseaseabout 10 years ago
Specialty Pipeline Highlightsabout 10 years ago
Limited-Distribution Products-The Debate Continuesabout 10 years ago
Health Systems: Discovering Specialty Pharmacyabout 10 years ago
Analytics for Specialty: Managing Patient OutcomesNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.